04 August 2020
The Global Fund has announced the appointment of three leading global health experts to head the organization’s HIV, Tuberculosis and Malaria teams to accelerate action to fight the three diseases.
Siobhan Crowley has been appointed Head of HIV, Eliud Wandwalo as Head of Tuberculosis and Scott Filler as Head of Malaria.
In their new roles, the appointees will develop and expand highly effective teams of senior disease advisors with the primary role of supporting Global Fund country teams, strengthening collaboration and alignment on key opportunities across the Global Fund Secretariat and deepening technical partner engagement to strengthen in-country results.
Crowley is a medical doctor with training in HIV and sexual and reproductive medicine, health education, public health evaluation and infectious diseases. She has held a range of clinical and technical positions with the UK’s National Health Service and has over 15 years’ experience in senior technical and executive roles with the United Nations and the non-profit sector internationally. Crowley’s experience includes developing evidence-based public health policy including enabling people living with HIV to contribute to WHO global standards on treatment and care.
Wandwalo is a medical doctor with over 23 years of public health experience. He joined the Global Fund in 2013. Before his time at the Fund, Wandwalo worked with Management Sciences for Health as the Principal Technical Advisor where he provided advice on the organization’s TB projects. Wandwalo also worked for the Ministry of Health’s National TB Program in Tanzania for over 10 years where he was responsible for establishing TB/HIV interventions as well as developing community-based TB programs. Wandwalo completed his medical training from University of Dar Es Salaam, Tanzania, with master's and PhD studies from Bergen University in Norway.
Filler has been with the Global Fund since 2011, leading the malaria response. He is a medical epidemiologist, originally a clinician with training in applied biostatistics and infectious diseases. Filler came to the Global Fund from the United States' Centers for Disease Control. His primary focus had been conducting operational research, translating research into policy and implementing large scale malaria and HIV programs. He has worked both for the US President's Malaria Initiative (PMI) and for the President's Emergency Plan for AIDS Relief (PEPFAR).
The new appointments replace the previous Senior Disease Coordinator roles to increase and elevate the Global Fund's technical expertise to accelerate in-country results. All three appointments are the result of a competitive recruitment process.